Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
fda
2
×
indiana blog main
indiana top stories
2
×
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
alprazolam
amgen
biotech
blueprint medicines
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
drug enforcement administration
drugs
eli lilly
entrectinib
express scripts
foundation medicine
indiana
josh bilenker
keytruda
larotrectinib
lasmiditan
loxo oncology
melanie nallicheri
merck
migraine research foundation
national
What
drug
fda
new
oks
second
2
×
acute
addresses
approval
approved
cancer
causes
condition
decades
deeper
dna
eli
fingerprint
friday
genetic
giant
giving
going
lasmiditan
lilly
lilly’s
matter
medication
medicine
migraine
nd
pharmaceutical
targets
time
tissues
tumor's
won
world
Language
unset
Current search:
second
×
fda
×
" indiana top stories "
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues